stakehigh
JF-Expert Member
- Aug 9, 2019
- 7,134
- 4,556
Nicosia.A 39-year-old British woman died in a Cypriot hospital after a blood clotting incident after receiving the AstraZeneca Covid-19 vaccine, the official Cyprus News Agency said Monday.
Charalambos Charilaou, the spokesperson for the state health services, told CNA that the European Medicines Agency (EMA) would investigate the death.
The woman, treated at Nicosia General Hospital's intensive care unit, received the first dose of the vaccine on May 6 in the resort town of Paphos on the western coast of the Mediterranean island.
The woman, who was not named, suffered symptoms days later.
Cyprus health authorities have opened an investigation to see if the "serious thrombotic episode" was linked to the AstraZeneca jab.
Cypriot authorities are investigating another four other cases of "mild" blood clotting incidents -- three of which occurred after an AstraZeneca shot and one after a Pfizer jab -- are also being investigated by Cyprus.
Some countries have restricted or dropped AstraZeneca shots from national vaccine campaigns over very rare blood clots, though the EMA says the benefits outweigh the risks.
AstraZeneca is the backbone of the vaccination rollout in Cyprus, where family doctors are also allowed to administer the jab to anybody aged over 20.
But many people booking online to get the vaccine have snubbed AstraZeneca and opted for other shots.
According to Our World in Data figures, Cyprus is ranked third in the European Union for vaccinations per population, administering 57.54 doses per 100 people.
Nearly 49 percent of Cyprus' adult population has received a Covid-19 vaccine shot, and 21 percent are fully vaccinated.
Total infections since the pandemic in March 2020 started is 71,911 and 354 deaths.
www.thecitizen.co.tz
www.jamiiforums.com
www.jamiiforums.com
Charalambos Charilaou, the spokesperson for the state health services, told CNA that the European Medicines Agency (EMA) would investigate the death.
The woman, treated at Nicosia General Hospital's intensive care unit, received the first dose of the vaccine on May 6 in the resort town of Paphos on the western coast of the Mediterranean island.
The woman, who was not named, suffered symptoms days later.
Cyprus health authorities have opened an investigation to see if the "serious thrombotic episode" was linked to the AstraZeneca jab.
Cypriot authorities are investigating another four other cases of "mild" blood clotting incidents -- three of which occurred after an AstraZeneca shot and one after a Pfizer jab -- are also being investigated by Cyprus.
Some countries have restricted or dropped AstraZeneca shots from national vaccine campaigns over very rare blood clots, though the EMA says the benefits outweigh the risks.
AstraZeneca is the backbone of the vaccination rollout in Cyprus, where family doctors are also allowed to administer the jab to anybody aged over 20.
But many people booking online to get the vaccine have snubbed AstraZeneca and opted for other shots.
According to Our World in Data figures, Cyprus is ranked third in the European Union for vaccinations per population, administering 57.54 doses per 100 people.
Nearly 49 percent of Cyprus' adult population has received a Covid-19 vaccine shot, and 21 percent are fully vaccinated.
Total infections since the pandemic in March 2020 started is 71,911 and 354 deaths.
British woman dies in Cyprus after AstraZeneca jab
Authorities are investigating to see if the "serious thrombotic episode" was linked to the jab.
#COVID19 - Mtangazaji wa NTV ya Kenya, Amina Abdi afiwa na bibi yake baada ya kupewa chanjo ya COVID-19
- Mengi yanaendelea kuhusu chanjo ya covid ambayo ilitolewa ndan ya miezi michache tu na tukalazimishwa kuchanjwa wote bila kuuliza maswali, sasa taarifa nnayotoka kuskiliza apa ni kwamba achana na wale wa blood clotting, sasa hivi imepiga hatua zaidi izi taarifa zimfikie mbowe
UK reports 32 deaths from clots after AstraZeneca jabs
A total of 168 people have suffered rare blood clots after taking the AstraZeneca coronavirus vaccine in Britain, and 32 have died, the UK's medicines regulator said Thursday. The figures for clots or "thromboembolic events" run up to April 14, by when 21.2 million people had received first...